Mar 11, 2024

Mar 11, 2024

Mar 11, 2024

20th BioPharma Drug Discovery Nexus Conference

Join Model Medicines in San Diego, California, on May 8-9 for the 20th BioPharma Drug Discovery Nexus Conference.

Daniel Haders, the CEO of Model Medicines, will be participating as a panelist, bringing his expertise to the conference. The event covers a wide range of drug discovery topics and offers excellent networking opportunities. Daniel will delve into the theme "Advancing Hit Discovery for Complex and Emerging Targets," aligning seamlessly with Model Medicines' groundbreaking work.

Contact

For more information about Model Medicines post-conference, visit www.modelmedicines.com/investors or get in touch with us directly.

Details

Date

Mar 11, 2024

Category

Events

Reading

2 Mins

Author

Patrick ONeill

Investor Relations

Related News

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases